Avidity Biosciences
RNA
#1875
Rank
HK$84.99 B
Marketcap
HK$564.07
Share price
0.00%
Change (1 day)
145.91%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: HK$84.99 Billion

As of January 2026 Avidity Biosciences has a market cap of HK$84.99 Billion. This makes Avidity Biosciences the world's 1875th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$84.99 B0.51%
2025HK$84.56 B203.2%
2024HK$27.88 B398.36%
2023HK$5.59 B-51.43%
2022HK$11.52 B32.57%
2021HK$8.69 B17.08%
2020HK$7.42 B

End of Day market cap according to different sources

On Jan 10th, 2026 the market cap of Avidity Biosciences was reported to be:

HK$84.99 Billion
by Nasdaq info icon info icon
HK$84.99 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
HK$48.51 B-42.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
HK$6.39 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$19.46 B-77.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
HK$21.76 B-74.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
HK$0.94 B-98.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
HK$85.20 B 0.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.129 T 1,228.56%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$793.77 B 833.94%๐Ÿ‡ฌ๐Ÿ‡ง UK